Mental Health Archives

Healthcare Industry News Weekly Wrap-Up: February 9, 2024

// Biotech and Pharma Therapeutics BridgeBio sells partial rights to dwarfism drug for $100M February 7, 2024 / BridgeBio / Kyowa Kirin / BioMarin Achondroplasia is the most common form of dwarfism and is caused by alterations to a gene...

February 9, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: November 10, 2023

// Biotech and Pharma Therapeutics AstraZeneca Pays $185M to Add Oral GLP-1 Drug Candidate to Pipeline November 9, 2023 / AstraZeneca / GLP-1 / Metabolic Disorder The available metabolic disorder drugs targeting the GLP-1 receptor are all injectable products. The...

November 10, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: November 3, 2023

// Biotech and Pharma Therapeutics GSK outpaces Pfizer in RSV vaccine market November 1, 2023 / GSK / Pfizer / RSV / Vaccine Though RSV is responsible for thousands of deaths and hospitalizations each year among young children and seniors,...

November 3, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: October 20, 2023

// Biotech and Pharma Therapeutics Bayer opens California plant to make cell therapies October 10, 2023 / Bayer / California / Cell Therapies / Parkinson’s The new facility is the latest investment from Bayer into cell and gene therapy. Bayer has...

October 20, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: June 30, 2023

// Biotech and Pharma Therapeutics Pfizer’s Litfulo enters the scene in alopecia with adolescent nod to rival Lilly’s Olumiant June 26, 2023 / Pfizer / Alopecia / FDA Approval / U.S. FDA On the heels of Eli Lilly’s landmark approval...

June 30, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: May 5, 2022

// Biotech and Pharma Therapeutics Astellas keeps the big buyouts rolling, inking $5.9B Iveric takeover ahead of FDA eye disease ruling May 1, 2023 / Astella Pharma / Iveric bio / Mergers and Acquisitions / Eye Disease The multibillion-dollar biotech...

May 5, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 17, 2023

// Biotech and Pharma Therapeutics Faced with safety issues over inflammation drug, AstraZeneca spinout Aristea closes shop February 10, 2023 / Biotech closure / Inflammation Things seemed to be going well for Aristea as recently as last November, with the...

February 17, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 10, 2023

// Biotech and Pharma Therapeutics AstraZeneca deals another blow to IL-12, dumping therapy to follow BMS, Merck KGaA out of race February 9, 2023 / AstraZeneca / Cytokines / Immuno-oncology / Solid Tumor Big Pharma involvement in IL-12 is fading...

February 10, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 13, 2023

// Biotech and Pharma Therapeutics J&J puts focus on cancer drugs in push to reach 2025 sales target January 24, 2023 / J&J / Cancer Drugs / Drugmaker Johnson & Johnson is confident it can reach its target of $60...

January 13, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 2, 2022

// Biotech and Pharma Therapeutics AstraZeneca beefs up COPD pipeline with $400M biobuck bet on C4X program November 28, 2022 / AstraZeneca / Chronic Obstructive Pulmonary Disease / Licensing Deals / Respiratory Diseases AstraZeneca has moved to strengthen its respiratory...

December 2, 2022

1 2 … 4 5 6

Tag: Mental Health